AzTrials
AzTrials

Postoperative Cognitive DysfunctionNCT04606888

Transcutaneous Electrical Acupoint Stimulation for Postoperative Cognitive Dysfunction

A study testing Transcutaneous electrical acupoint stimulation in people with Postoperative Cognitive Dysfunction, run by Subei People's Hospital of Jiangsu Province at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postoperative cognitive dysfunction (POCD) is one of the common complications of cancer patients after operation with a 8.9%-46.1% incidence, which severely affecting patients' postoperative recovery, increasing the medical cost, affecting the social function of patients, reducing the quality of life and increasing… Read more about this study

Who is it for?
Ages 60 to 90 years
Conditions the study is for
Postoperative Cognitive Dysfunction
What is being tested?
Transcutaneous electrical acupoint stimulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
64 participants
Where
1 siteChina
Study dates
1 Jul 2020to 30 Sep 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients aged 60 years or older;
  • Patients were diagnosed with gastrointestinal tumor and received radical; resection of gastrointestinal tumors under general anesthesia in Subei people's hospital of Jiangsu province;
  • The patients understood the research content and signed the informed consent form;
  • American Society of Anesthesiology (ASA) score I-III;
  • No frailty before operation;
  • D-dimer was normal before the operation

Who cannot join

  • Patients with cognitive dysfunction before the operation or patients with previous history of cognitive dysfunction, dementia and delirium;
  • Patients with a history of severe depression, schizophrenia and other mental and nervous system diseases or taking antipsychotic or antidepressant drugs in the past;
  • Patients with severe hearing or visual impairment due to eye or ear diseases without assistive tools;
  • Patients who are unable to communicate or have difficulty communicating;
  • According to the definition of "China chronic disease and its risk factors monitoring report (2010)" (male average daily pure alcohol intake ≥ 61g, female average daily pure alcohol intake ≥ 41g, alcohol volume (g) = alcohol consumption (ML) × alcohol content% × 0.8);
  • Patients who were hospitalized for three months or more before surgery or who had received surgical treatment within three months;
Show all 14Show fewer
  • Patients who can't take care of themselves or are physically disabled and unable to carry out nerve function test;
  • Patients with severe heart, liver and renal failure;
  • Patients with hypoxemia (blood oxygen saturation < 94%) more than 10 minutes during operation;
  • Patients admitted to ICU after operation;
  • Patients who quit or died due to noncooperation or sudden situation;
  • Patients who already participate in other clinical studies which may influence this study;
  • Patient who underwent emergency surgery;
  • Patient had a history of recent or conventional acupuncture treatment.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Northern Jiangsu People's Hospital

    Yangzhou, Jiangsu, 225001

Other trials in China

About this study

Official title: Transcutaneous Electrical Acupoint Stimulation for Postoperative Cognitive Dysfunction in Geriatric Patients With Gastrointestinal Tumor

Postoperative cognitive dysfunction (POCD) is one of the common complications of cancer patients after operation with a 8.9%-46.1% incidence, which severely affecting patients' postoperative recovery, increasing the medical cost, affecting the social function of patients, reducing the quality of life and increasing the mortality.

Surgical trauma and perioperative pain can induce systematic inflammatory response and release systematic inflammatory mediators, which can enter the central nervous system (CNS) and lead to CNS inflammatory. In order to prevent the development of POCD among elder patients, the discovery of effective interventions reducing perioperative pain and inflammatory response is important.

Read more

Transcutaneous Electrical Acupoint Stimulation (TEAS) is a non-invasive alternative to needle-based electro-acupuncture (EA). It combines the acupuncture and transcutaneous electrical nerve stimulation (TENS) by pasting the electrode piece on the acupoint instead of sticking the needles on the skin. TEAS can trigger the release of endogenous neurotransmitters, releasing endogenous analgesic substances, such as endorphins. TEAS also can reduce the intraoperative anesthetic consumption, postoperative pain score, postoperative nausea and vomiting (PONV), and improve the postoperative recovery of patients. Recently, TEAS was found to improve the cognitive function of geriatric patients with silent lacunar infarction. However, the current TEAS mainly focus on intraoperative. The effect of perioperative TEAS on POCD is not clear.

Here, the effect of TEAS on POCD in geriatric adults undergoing radical resection of gastrointestinal tumors under general anesthesia was investigated to determine whether TEAS can decrease perioperative pain or inflammatory response to prevent the occurrence of POCD and to find out the relationship among perioperative TEAS, inflammatory response, postoperative pain, and POCD preliminarily.

Read the detailed description

This study aims to evaluate the effect of perioperative transcutaneous electrical acupoint stimulation (TEAS) on postoperative cognitive dysfunction (POCD) in elderly patients who were diagnosed with gastrointestinal tumor and received radical resection of gastrointestinal tumors under general anesthesia and to determine the relationship among perioperative TEAS, inflammatory response, postoperative pain, and POCD preliminarily.

Being tested
Transcutaneous electrical acupoint stimulation
Keywords
POCD, TEAS, Gastrointestinal tumor
Medical subject headings
Postoperative Cognitive Complications, Digestive System Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transcutaneous electrical acupoint stimulationDevice

    According to the traditional Chinese medicine 15,three acupuncture points were selected as the target points: bilateral Neiguan ,Yintang and bilateral Zusanli.. A transcutaneous electrical stimulator was used to provide an altered frequency 2/100 Hz,disperse-dense waves,and adjusted intensity which was less than 10mA.

Study groups in NCT04606888
Study groupRoleWhat they receive
Transcutaneous electrical acupoint stimulation groupExperimentalTranscutaneous electrical acupoint stimulation group patients received Transcutaneous electrical acupoint stimulation (Neiguan [PC6], Yintang [GV 29], Zusanli [ST36]) for 30 min before the induction of anaesthesia until the end of the surgery and the night before operation, the first, second and third night after operation 30 min once a day with an altered frequency 2/100 Hz, disperse-dense waves, adjusted electricity intensity which was less than 10 mA.
Receives: Device: Transcutaneous electrical acupoint stimulation
Control groupNo interventionIn Control group, except the electronic stimulation was not applied, the treatment was the same as the Transcutaneous electrical acupoint stimulation group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mini-Mental State Examination score

    Assess the cognitive function of the patient,the minimum value is 0,and the maximum value is 30, higher scores mean a better outcome.

    Measured: In the morning of the day before operation

  2. Mini-Mental State Examination score

    Assess the cognitive function of the patient,the minimum value is 0,and the maximum value is 30, higher scores mean a better outcome.

    Measured: Three days after operation

  3. C reactive protein

    Assess the inflammatory reaction of the patient

    Measured: The day before operation.

  4. C reactive protein

    Assess the inflammatory reaction of the patient

    Measured: The 1st day after the operation.

  5. C reactive protein

    Assess the inflammatory reaction of the patient

    Measured: The 3rd day after the operation.

  6. Interleukin-6

    Assess the inflammatory reaction of the patient

    Measured: The day before operation.

  7. Interleukin-6

    Assess the inflammatory reaction of the patient

    Measured: The 1st day after the operation.

  8. Interleukin-6

    Assess the inflammatory reaction of the patient

    Measured: The 3rd day after the operation.

  9. S100 calcium-binding protein β

    Assess the inflammatory reaction of the patient

    Measured: The day before operation.

  10. S100 calcium-binding protein β

    Assess the inflammatory reaction of the patient

    Measured: The 1st day after the operation.

  11. S100 calcium-binding protein β

    Assess the inflammatory reaction of the patient

    Measured: The 3rd day after the operation.

Secondary outcomes (5)
  1. Numeric Rating Scale score

    Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.

    Measured: The day before operation

  2. Numeric Rating Scale score

    Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.

    Measured: The day of operation

  3. Numeric Rating Scale score

    Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.

    Measured: The 1st day after the operation.

  4. Numeric Rating Scale score

    Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.

    Measured: The 2rd day after the operation.

  5. Numeric Rating Scale score

    Assess the pain score of the patient,the minimum value is 0,and the maximum value is 10, higher scores mean a worse outcome.

    Measured: The 3nd day after the operation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2020
  2. Study start1 Jul 2020
  3. Primary completion30 Sep 2020
  4. Study completion30 Sep 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Transcutaneous electrical acupoint stimulation group and control group
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04606888
Sponsor's protocol ID
LijuanXi
Status last verified
Oct 2020
First submitted
16 Oct 2020
Last updated
29 Oct 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Underlie results in a publication

Publications

  • Correction: Influence of postoperative analgesia on systemic inflammatory response and postoperative cognitive dysfunction after femoral fractures surgery: a randomized controlled trial. Reg Anesth Pain Med. 2019 Oct;44(10):e2. doi: 10.1136/rapm-2018-000023corr1. No abstract available.

    PubMed 31534004
  • Li Y, Huang D, Su D, Chen J, Yang L. Postoperative cognitive dysfunction after robot-assisted radical cystectomy (RARC) with cerebral oxygen monitoring an observational prospective cohort pilot study. BMC Anesthesiol. 2019 Nov 6;19(1):202. doi: 10.1186/s12871-019-0877-5.

    PubMed 31694553
  • Rasmussen LS, Johnson T, Kuipers HM, Kristensen D, Siersma VD, Vila P, Jolles J, Papaioannou A, Abildstrom H, Silverstein JH, Bonal JA, Raeder J, Nielsen IK, Korttila K, Munoz L, Dodds C, Hanning CD, Moller JT; ISPOCD2(International Study of Postoperative Cognitive Dysfunction) Investigators. Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand. 2003 Mar;47(3):260-6. doi: 10.1034/j.1399-6576.2003.00057.x.

    PubMed 12648190
  • Evered LA, Silbert BS. Postoperative Cognitive Dysfunction and Noncardiac Surgery. Anesth Analg. 2018 Aug;127(2):496-505. doi: 10.1213/ANE.0000000000003514.

    PubMed 29889707
  • Borges J, Moreira J, Moreira A, Santos A, Abelha FJ. [Impact of postoperative cognitive decline in quality of life: a prospective study]. Rev Bras Anestesiol. 2017 Jul-Aug;67(4):362-369. doi: 10.1016/j.bjan.2016.07.007. Epub 2017 Apr 12. Portuguese.

    PubMed 28412051
  • Kotekar N, Shenkar A, Nagaraj R. Postoperative cognitive dysfunction - current preventive strategies. Clin Interv Aging. 2018 Nov 8;13:2267-2273. doi: 10.2147/CIA.S133896. eCollection 2018.

    PubMed 30519008
  • Huang JM, Lv ZT, Zhang B, Jiang WX, Nie MB. Intravenous parecoxib for early postoperative cognitive dysfunction in elderly patients: evidence from a meta-analysis. Expert Rev Clin Pharmacol. 2020 Apr;13(4):451-460. doi: 10.1080/17512433.2020.1732815. Epub 2020 Feb 28.

    PubMed 32077347
  • Yang W, Kong LS, Zhu XX, Wang RX, Liu Y, Chen LR. Effect of dexmedetomidine on postoperative cognitive dysfunction and inflammation in patients after general anaesthesia: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2019 May;98(18):e15383. doi: 10.1097/MD.0000000000015383.

    PubMed 31045788
  • Lv ZT, Huang JM, Zhang JM, Zhang JM, Guo JF, Chen AM. Effect of Ulinastatin in the Treatment of Postperative Cognitive Dysfunction: Review of Current Literature. Biomed Res Int. 2016;2016:2571080. doi: 10.1155/2016/2571080. Epub 2016 Aug 14.

    PubMed 27597957
  • Deng LQ, Hou LN, Song FX, Zhu HY, Zhao HY, Chen G, Li JJ. Effect of pre-emptive analgesia by continuous femoral nerve block on early postoperative cognitive function following total knee arthroplasty in elderly patients. Exp Ther Med. 2017 Apr;13(4):1592-1597. doi: 10.3892/etm.2017.4099. Epub 2017 Feb 3.

    PubMed 28413514
  • Zhang Q, Gao Z, Wang H, Ma L, Guo F, Zhong H, Xiong L, Wang Q. The effect of pre-treatment with transcutaneous electrical acupoint stimulation on the quality of recovery after ambulatory breast surgery: a prospective, randomised controlled trial. Anaesthesia. 2014 Aug;69(8):832-9. doi: 10.1111/anae.12639. Epub 2014 May 28.

    PubMed 24865978
  • Gao F, Zhang Q, Li Y, Tai Y, Xin X, Wang X, Wang Q. Transcutaneous electrical acupoint stimulation for prevention of postoperative delirium in geriatric patients with silent lacunar infarction: a preliminary study. Clin Interv Aging. 2018 Oct 24;13:2127-2134. doi: 10.2147/CIA.S183698. eCollection 2018.

    PubMed 30425466
  • Xi L, Fang F, Yuan H, Wang D. Transcutaneous electrical acupoint stimulation for postoperative cognitive dysfunction in geriatric patients with gastrointestinal tumor: a randomized controlled trial. Trials. 2021 Aug 23;22(1):563. doi: 10.1186/s13063-021-05534-9.

    PubMed 34425851

Questions about this trial

What is this clinical trial studying?

A study testing Transcutaneous electrical acupoint stimulation in people with Postoperative Cognitive Dysfunction, run by Subei People's Hospital of Jiangsu Province at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mini-Mental State Examination score (time frame: In the morning of the day before operation). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04606888, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in